Protein | Observation | Reference |
---|---|---|
CD9 | Up-regulated during allergy season | [1] |
CD40 | Correlates inversely with esophagus eosinophilia in EoE | [6] |
CD44 | Higher in well-controlled than in poorly controlled asthma | [1] |
Down-regulated in EoE | [5] | |
CD45RO | Up-regulated in mild-moderate asthma | [1] |
CD48 | Up-regulated in allergic asthma | [1] |
CD66b (CEACAM8) | Up-regulated in untreated EoE | [133] |
CD69 | Up-regulated in severe atopic dermatitis | [10] |
CD137 (TNFRSF9, ILA, 4-1BB) | Up-regulated in atopic dermatitis and allergic asthma | [134] |
αL integrin (CD11a) | Up-regulated in allergic asthma | [1] |
αM integrin (CD11b) | Up-regulated during allergy season | [1] |
Correlates inversely with PC20 | ||
αX integrin (CD11c) | Up-regulated in EoE | [5] |
β2 integrin (CD18) | Correlates with esophagus eosinophilia in EoE | [6] |
CCR3 | Down-regulated in EoE | [5] |
Correlates inversely with esophagus eosinophilia in EoE | [6] | |
CRTH2 (Prostaglandin D2 R2, CD294) | Up-regulated in EoE | [5] |
FcαRI (CD89) | Up-regulated in allergic rhinitis or allergic asthma | [1] |
FcεRII (CD23) | Up-regulated in EoE | [5] |
FcγRIII (CD16) | Up-regulated in allergic rhinitis or allergic asthma | [1] |
Galectin-3 | Up-regulated in allergy | [1] |
ICAM-1 (CD54) | Up-regulated in EoE | [5] |
IL-2Rα (CD25) | Up-regulated in some patients with asthma | [7] |
IL-17RA (subunit of IL- 25R) | Up-regulated in mild allergic asthma | [1] |
IL-17RB (subunit of IL- 25R) | Up-regulated in mild allergic asthma | [1] |
Neuropeptide S receptor | Up-regulated in severe asthma | [1] |
Activated β1 integrin (CD29) | Intermediate-activity state (recognized by mAb N29) increased in non-severe but not severe asthma | [1] |
Correlates inversely with FEV1 after or during ICS withdrawal in mild asthma and predicts decreased FEV1 in ROC curve analysis | ||
Correlates with FENO after ICS withdrawal in mild asthma | ||
Correlates inversely with FEV1/FVC in younger subjects with non-severe asthma | ||
Correlates inversely with FEV1/FVC in phenotype cluster 1 (mild atopic asthma). | ||
At 48Â h after segmental lung antigen challenge, correlates with late-phase FEV1 fall after whole-lung antigen challenge in mild allergic asthma | ||
Activated β2 integrin (CD18) | Intermediate-activity state (recognized by mAb KIM-127) correlates with BAL eosinophilia in mild allergic asthma | [1] |
Activated FcγRII (CD32) | Activated state (recognized by mAb A17 or A27) increased in mild asthma | [1] |
Correlates with FENO in asthma |